NY State Senate Bill 2019-S932

Senate Bill S932

2019-2020 Legislative Session

Establishes the clinical trial access and education fund to provide grants for certain services for patients with life-threatening or disabling conditions/diseases

download bill text pdf

Archive: Last Bill Status - In Senate Committee Health Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 08, 2020	referred to health
Jan 09, 2019	referred to health

co-Sponsors

2019-S932 (ACTIVE) - Details

See Assembly Version of this Bill:: A1035
Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Add §2424, Pub Health L
Versions Introduced in Other Legislative Sessions:: 2009-2010: A1805
2011-2012: A807
2013-2014: S6442, A2688
2015-2016: S777, A1567
2017-2018: S1216, A2538
2021-2022: S1169, A180
2023-2024: S4793

2019-S932 (ACTIVE) - Summary

Establishes the clinical trial access and education fund to provide grants to eligible applicants to provide certain services for patients with life-threatening or disabling conditions or diseases.

2019-S932 (ACTIVE) - Sponsor Memo

                                
 
BILL NUMBER: S932

SPONSOR: RIVERA
 
TITLE OF BILL:  An act to amend the public health law, in relation to
establishing the clinical trial access and education fund

 
PURPOSE OR GENERAL IDEA OF BILL:

This bill creates the Clinical Trial Access and Education Fund, a state
grant program within the department to provide funding to address the
major barriers to participation in clinical trials in New York State.

 
SUMMARY OF SPECIFIC PROVISIONS:

Section 1 amends article 24 of the public health law by adding a new
section 2424, the Clinical Trial Access and Education Fund.

Subdivision 1 of the new section provides definitions of eligible appli-
cant and clinical trial.

Subdivision 2 establishes the clinical trial access and education fund

within the department to provide grants to eligible applicants on a
competitive request for proposal basis to provide certain services to
patients with life-threatening or disabling conditions or diseases.
Such services would include: transportation and lodging to patients so
they may access a clinical trial or related treatment; patient outreach
and education on the existence of and how to enroll in clinical trials;
and patient navigation services to help patients determine eligibility
for clinical trials.

Subdivision 3 establishes an application process for eligible applicants
and states that the commissioner shall give Preference to applicants who
have experience and expertise providing patient outreach, education,
navigation and other services to patients with life-threatening or disa-
bling conditions or diseases.

Subdivision 4 requires grantees to file an annual report with the
commissioner summarizing how they utilized the grant funds to increase
patient access to clinical trials.

Subdivision 5 requires the commissioner to make any necessary regu-
lations to implement the section.

Section 2 establishes the effective date.

 
JUSTIFICATION:

New therapies to treat cancer and other life threatening diseases are
being developed at an increasing pace. Clinical trials are the most
effective, scientifically valid method of determining the benefits of
experimental treatments. They are critical to improving health care and
mortality rates for patients with cancer and other life-threatening
diseases.

While fewer thanof adult cancer patients participate in clinical
trials,of pediatric cancer patients do. This large number of pedia- tric
enrollees has led to the discovery of groundbreaking therapies and a
survival rate of over 80 for childhood cancer. To achieve a similar rate
of success for adults with cancer and other diseases, information and
access to clinical trials must be made more widely available to patients
and their treating health care providers.,

A number of studies have looked at the reasons for low adult patient
participation in clinical trials. One recent study conducted by the
University of California Davis Cancer Center surveyed oncologists
regarding patient and physician decision-making about participation in
clinical trials. Of the 276 patients assessed, oncologists only recom-
mended that 76 patients participate in clinical trials and only 39
patients or l4 actually enrolled in the trials. The two most common
reasons that patients cited for declining to participate were a desire
for other treatment and the distance from the cancer center.  The study
authors made a series of recommendations to overcome these barriers
including the need for greater physician and patient education on the
status, availability and benefits of clinical trials as well as the need
to address geographical issues that serve as strong deterrents to clin-
ical trial access.

The Clinical Trial Access and Education Fund will address these major
barriers identified by the clinical research and anecdotally from
patients and providers in New York, it will provide grants to non-for-
profit community groups, health care provider associations and research
centers that conduct clinical trials so they may provide and/ or facili-
tate patient navigation, transportation, lodging and patient and provid-
er education to achieve greater patient participation in clinical
trials.

 
PRIOR LEGISLATIVE HISTORY:

2014: S6442
2015-2016: 5777
2017-2018: 51216

 
FISCAL IMPLICATIONS:

None - subject to available appropriations.

 
EFFECTIVE DATE:
This act shall take effect immediately.

2019-S932 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                    932
 
                        2019-2020 Regular Sessions
 
                             I N  S E N A T E
 
                              January 9, 2019
                                ___________
 
 Introduced by Sens. RIVERA, SEPULVEDA -- read twice and ordered printed,
   and when printed to be committed to the Committee on Health
 
 AN  ACT  to amend the public health law, in relation to establishing the
   clinical trial access and education fund
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  The  public health law is amended by adding a new section
 2424 to read as follows:
   § 2424. CLINICAL TRIAL ACCESS AND EDUCATION FUND. 1. DEFINITIONS.  FOR
 THE PURPOSES OF THIS SECTION, THE FOLLOWING TERMS SHALL HAVE THE FOLLOW-
 ING MEANINGS:
   A. "ELIGIBLE APPLICANT" MEANS (I) A MEDICAL  SCHOOL  THAT  SPONSORS  A
 CLINICAL  TRIAL,  (II) A NOT-FOR-PROFIT ORGANIZATION WITH EXPERIENCE AND
 EXPERTISE WORKING  WITH  PATIENTS  WITH  LIFE-THREATENING  OR  DISABLING
 CONDITIONS OR DISEASES, (III) A HEALTH CARE PROVIDER ORGANIZATION, ASSO-
 CIATION  OR  SOCIETY, (IV) A GENERAL HOSPITAL DEFINED IN ARTICLE TWENTY-
 EIGHT OF THIS CHAPTER, (V) A COUNTY OR CITY HEALTH DEPARTMENT, OR (VI) A
 MUNICIPALITY.
   B. "CLINICAL TRIAL" SHALL HAVE THE  SAME  MEANING  AS  IN  SUBDIVISION
 TWO-B OF SECTION FORTY-NINE HUNDRED OF THIS CHAPTER.
   2.  ESTABLISHMENT  OF  FUND.  THERE  IS  HEREBY ESTABLISHED WITHIN THE
 DEPARTMENT A CLINICAL TRIAL ACCESS AND EDUCATION FUND. SUBJECT TO APPRO-
 PRIATIONS, THE DEPARTMENT SHALL PROVIDE GRANTS TO ELIGIBLE APPLICANTS ON
 A COMPETITIVE REQUEST FOR PROPOSAL BASIS TO PROVIDE ONE OR MORE  OF  THE
 FOLLOWING SERVICES TO PATIENTS WITH LIFE-THREATENING OR DISABLING CONDI-
 TIONS  OR  DISEASES,  AS  SUCH  TERMS  ARE DEFINED IN SECTION FORTY-NINE
 HUNDRED OF THIS CHAPTER, TO FACILITATE ACCESS TO OR EDUCATION  ON  CLIN-
 ICAL TRIALS OF TREATMENTS FOR THE PATIENT'S CONDITION OR DISEASE:
   A. TRANSPORTATION SERVICES AND LODGING TO PROVIDE PATIENTS WITH ACCESS
 TO CLINICAL TRIALS OR OTHER RELATED TREATMENTS WHILE ENROLLED IN A CLIN-
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD03367-01-9

 S. 932                              2
 
 ICAL  TRIAL OR TO ACCESS TESTING AND OTHER SERVICES TO DETERMINE PATIENT
 ELIGIBILITY FOR A CLINICAL TRIAL;
   B.  PATIENT OUTREACH AND EDUCATION SERVICES TO EDUCATE PATIENTS, THEIR
 FAMILIES AND HEALTH CARE  PROVIDERS  ABOUT  THE  EXISTENCE  OF  AND  HOW
 PATIENTS  MAY ENROLL IN CLINICAL TRIALS, UNDER SECTION TWO HUNDRED SEVEN
 OF THIS CHAPTER; AND
   C. PATIENT NAVIGATION SERVICES TO HELP PATIENTS TO DETERMINE  IF  THEY
 ARE ELIGIBLE FOR CLINICAL TRIALS, TO HELP PATIENTS TO ENROLL IN CLINICAL
 TRIALS  AND TO ASSIST PATIENTS IN DEALING WITH INSURANCE OR OTHER ISSUES
 WHICH SERVE AS BARRIERS TO PATIENT ENROLLMENT IN CLINICAL TRIALS.
   3. APPLICATIONS. THE COMMISSIONER SHALL ESTABLISH AN APPLICATION PROC-
 ESS BY WHICH ELIGIBLE APPLICANTS  MAY  APPLY  FOR  A  GRANT  UNDER  THIS
 SECTION.  THE APPLICATION SHALL INCLUDE:
   A. THE GEOGRAPHIC AREA IN WHICH THE SERVICES SHALL BE PROVIDED;
   B. A DETAILED DESCRIPTION OF THE SERVICES TO BE PROVIDED;
   C.  APPLICANT'S EXPERIENCE WORKING WITH PATIENTS WITH LIFE-THREATENING
 OR DISABLING CONDITIONS OR DISEASES;
   D. APPLICANT'S ABILITY TO PROVIDE PATIENT OUTREACH OR  CLINICAL  TRIAL
 EDUCATION  AND NAVIGATION SERVICES, OR COORDINATE OR PROVIDE TRANSPORTA-
 TION AND LODGING FOR PATIENTS; AND
   E. ANY OTHER INFORMATION THAT  THE  COMMISSIONER  DEEMS  RELEVANT  AND
 APPROPRIATE.
   THE COMMISSIONER SHALL GIVE PREFERENCE TO ELIGIBLE APPLICANTS WHO HAVE
 EXPERIENCE  AND EXPERTISE WORKING WITH PATIENTS WITH LIFE-THREATENING OR
 DISABLING CONDITIONS OR DISEASES AND PROVIDING PATIENT OUTREACH,  EDUCA-
 TION AND HEALTH CARE NAVIGATION SERVICES.
   4.  REPORTS. GRANTEES SHALL FILE AN ANNUAL REPORT WITH THE COMMISSION-
 ER, IN SUCH FORM AND WITH SUCH INFORMATION AND DATA AS THE  COMMISSIONER
 PRESCRIBES  DETAILING THE EXPENDITURE OF GRANT FUNDS AND SUMMARIZING THE
 EFFORTS UNDERTAKEN TO INCREASE PATIENT ACCESS TO CLINICAL TRIALS.
   5. THE COMMISSIONER SHALL MAKE  REGULATIONS  REASONABLY  NECESSARY  TO
 IMPLEMENT THE PROVISIONS OF THIS SECTION.
   § 2. This act shall take effect immediately.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S932

Share this bill

Sponsored By

Gustavo Rivera